Drug intelligence / Profile preview

hawthorn total flavonoids

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Hawthorn total flavonoids refers to the mixture of major flavonoids isolated and purified from hawthorn leaves, primarily from species such as Crataegus pinnatifida and related Crataegus species. The main active constituents include flavones, flavonols, dihydroflavones, dihydroflavonols, and flavanes, with specific compounds such as vitexin, hyperoside, rutin, chlorogenic acid, quercetin, isoquercitrin, and procyanidin B2 among others. Preclinical and clinical studies suggest a variety of pharmacological effects including strong antioxidant, anti-inflammatory, hypolipidemic, hepatoprotective, neuroprotective, and cardioprotective actions. Mechanistically, hawthorn flavonoids exert effects via free radical scavenging, inhibition of lipid peroxidation, promotion of autophagy, suppression of apoptosis, and modulation of signaling pathways such as PI3K/GSK3β/cyclin D1 in cardiovascular models. Hawthorn total flavonoids are widely available as dietary supplements and are a focus of research both as natural therapies and as adjuncts in metabolic, cardiovascular, and neurological disorders[3][4][6][7][2][1][8].

Other names
total flavonoids of hawthorn leavesTFHLtotal flavonoids from hawthorn leavestotal flavonoid extract from hawthornHLF
02

Targets

NeuraminidaseCCND1 (Cyclin D1)GSK3 (Glycogen synthase kinase 3 beta)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on hawthorn total flavonoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hawthorn total flavonoids.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call